This user has not added any information to their profile yet.
Koss, B, Shields, BD, Taylor, EM, Storey, AJ, Byrum, SD, et. al. EZH2 protects tumor-infiltrating lymphocytes from metabolic-stress induced cell death and exhaustion. Cancer Research, 2020, 80(21): 4707-4719.
Shields BD, Koss B, Storey AJ, Taylor EM, et al. E-cadherin loss enables melanoma checkpoint blockade resistance by escape from CD103 immune responses. Cancer Research (2019) 79, 1113–1123.
Koss B, Morrison J, Perciavalle RM, et al. Requirement for antiapoptotic MCL-1 in the survival of BCR-ABL B-lineage acute lymphoblastic leukemia. Blood. 2013;122(9):1587-1598. PMCID: PMC3757371
Koss B, Ryan J, Budhraja A, et al. Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines. Oncotarget. 2016;7(10):11500-11511. PMCID: PMC4905489
Tripathi P, Koss B, Opferman JT, Hildeman DA. Mcl-1 antagonizes Bax/Bak to promote effector CD4+ and CD8+ T-cell responses. Cell Death and Differentiation. 2013;20(8):998-1007. PMCID: PMC3705594
Complete List of Published Work in MyBibliography (17 total publications)